| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1943733-16-1 | N-(2-(5-Chloro-2-pyridinyl)ethyl)-4-((((4-methoxyphenyl)sulfonyl)amino)methyl)benzamide;YU 238259 | C22H22ClN3O4S |
| 1945965-95-6 | Ropivacaine EP Impurity F;(8as)-2-(2,6-dimethylphenyl)-3,3-dimethylhexahydroimidazo(1,5-a)pyridin-1(5H)-one | C17H24N2O |
| 1946806-94-5 | N-((1,1'-Biphenyl)-4-yl)-3'-(9H-carbazol-9-yl)-(1,1'-biphenyl)-4-amine;N-(4-(3-carbazol-9-ylphenyl)phenyl)-4-phenylaniline | C36H26N2 |
| 1948273-00-4 | (S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethanamine | C12H14N2S |
| 1948273-01-5 | (alphaS)-alpha-Methyl-4-(4-methyl-5-thiazolyl)benzenemethanamine hydrochloride (1:1);(S)-1-(4-(4-Methylthiazol-5-yl)phenyl)ethanamine hydrochloride | C12H14N2S.HCl |
| 1948273-02-6 | E3 ligase Ligand 1A;(2S,4R)-1-((2S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((1S)-1-(4-(4-methyl-1,3-thiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide | C23H32N4O3S |
| 1948273-03-7 | (4R)-3-Methyl-L-valyl-4-hydroxy-N-((1S)-1-(4-(4-methyl-5-thiazolyl)phenyl)ethyl)-L-prolinamide hydrochloride (1:1);E3 ligase Ligand 1 | C23H32N4O3S.HCl |
| 1951441-43-2 | trans-3-Fluorocyclohexanamine HCl;(1R,3R)-3-fluorocyclohexan-1-amine;hydrochloride | C6H13ClFN |
| 1951483-29-6 | 5,6-Dihydro-6,6-dimethyl-2-(2-((1-methyl-1H-pyrazol-5-yl)amino)-4-pyrimidinyl)-5-(2-(4-morpholinyl)ethyl)-4H-thieno(2,3-c)pyrrol-4-one | C22H27N7O2S |
| 1952236-05-3 | N-(2-Chloro-5-(4-((3-chloro-4-fluorophenyl)amino)-6-quinazolinyl)-3-pyridinyl)methanesulfonamide | C20H14Cl2FN5O2S |
| 1952316-43-6 | 4-(8-Amino-3-((2R)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinylbenzamide | C26H23N7O2 |
| 1952360-91-6 | Fmoc-N-amido-PEG12-propionic acid;3-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)propanoic acid | C42H65NO16 |
| 1953133-47-5 | (1R,3R)-1-(2,6-Difluoro-4-((1-(3-fluoropropyl)-3-azetidinyl)amino)phenyl)-β,β-difluoro-1,3,4,9-tetrahydro-3-methyl-2H-pyrido(3,4-b)indole-2-propanol;GDC 9545; Giredestrant; RG 6171; RG-6171; RG6171 | C27H31F5N4O |
| 1955474-17-5 | (S)-1-Phenylpyrrolidin-3-amine hydrochloride | C10H15ClN2 |
| 1955543-57-3 | 2-(3'-(9,9-Dimethyl-9H-fluoren-2-yl)-(1,1'-biphenyl)-3-yl)-4,6-diphenyl-1,3,5-triazine | C42H31N3 |
| 1956356-56-1 | (5Z)-5-((5-(4-Nitrophenyl)-2-furanyl)methylene)-4-oxo-2-thioxo-3-thiazolidinepropanoic acid potassium salt (1:1) | C17H11N2O6S2.K |
| 1956366-10-1 | 4-(5-Chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide hydrochloride (1:1) | C21H22Cl2N4O2.HCl |
| 1956380-24-7 | tert-Butyl 6-methylene-4-azaspiro(2.4)heptane-4-carboxylate | C12H19NO2 |
| 1956385-35-5 | 3-Bromo-8-(methylsulfonyl)quinoline | C10H8BrNO2S |
| 1956426-56-4 | N-(2-(((3-(4-Chlorophenyl)-2-propen-1-yl)methylamino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide hydrochloride (1:1) | C26H29ClN2O4S.HCl |
| 1956436-64-8 | Solifenacin Benzoyl (R)-Quinuclidinyl Impurity;(R)-Quinuclidin-3-yl 2-benzoylphenethylcarbamate;((3R)-1-azabicyclo(2.2.2)octan-3-yl) N-(2-(2-benzoylphenyl)ethyl)carbamate | C23H26N2O3 |
| 1958125-89-7 | (R)-2-amino-2-cyclobutylacetic acid hydrochloride;(2R)-2-amino-2-cyclobutylacetic acid;hydrochloride | C6H12ClNO2 |
| 1962925-29-6 | Nirogacestat Hydrobromide;(2S)-2-(((2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl)imidazol-4-yl)pentanamide;dihydrobromide | C27H43Br2F2N5O |
| 1965291-08-0 | Ibrexafungerp Citrate;(1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-((2R)-2-amino-2,3,3-trimethylbutoxy)-5,7,10,15-tetramethyl-7-((2R)-3-methylbutan-2-yl)-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo(13.3.3.01,14.02,11.05,10)henicos-2-ene-6-carboxylic acid;2-hydroxypropane-1,2,3-tricarboxylic acid | C50H75N5O11 |
| 1966941-11-6 | Rotigotine EP Impurity I;((6R)-6-(propyl(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-yl) 4-methylbenzenesulfonate | C26H31NO3S2 |
| 1971007-95-0 | N-((1-(Cyclohexylmethyl)-1H-indol-3-yl)carbonyl)-3-methyl-L-valine methyl ester | C23H32N2O3 |
| 1975982-94-5 | Osimertinib Impurity M;2-(5-methoxy-N-methyl-4-((4-(1-methylindol-3-yl)pyrimidin-2-yl)amino)-2-(prop-2-enoylamino)anilino)-N,N-dimethylethanamine oxide | C28H33N7O3 |
| 1980023-97-9 | (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine dihydrochloride | C10H13Cl2FN4 |
| 1980063-54-4 | 4-(Difluoromethyl)aniline hydrochloride | C7H8ClF2N |
| 1980785-05-4 | Methanesulfonato(Di-tert-butyl(2',4',6'-triisopropyl-3,6-dimethoxybiphenyl-2-yl)phosphine)(2'-methylamino-1,1'-biphenyl-2-yl)palladium(II) | C45H65NO5PPdS- |
| 1985606-14-1 | Baloxavir marboxil;({(12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,e)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-(1,4)oxazino(3,4-c)pyrido(2,1-f)(1,2,4)triazin-7-yl}oxy)methyl methyl carbonate; Baloxavir marboxil; S 033188; Xofluza | C27H23F2N3O7S |
| 1985607-70-2 | (12aR)-3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-(1,4)oxazino(3,4-c)pyrido(2,1-f)(1,2,4)triazine-6,8-dione;(3R)-11-phenylmethoxy-5-oxa-1,2,8-triazatricyclo(8.4.0.03,8)tetradeca-10,13-diene-9,12-dione | C17H17N3O4 |
| 1985607-83-7 | 7,8-Difluoro-6,11-dihydrodibenzo(b,e)thiepin-11-ol | C14H10F2OS |
| 1987887-92-2 | Nintedanib N-Methyl aniline analog;methyl 2-hydroxy-3-(N-(4-(methylamino)phenyl)-C-phenylcarbonimidoyl)-1H-indole-6-carboxylate | C24H21N3O3 |
| 1987905-93-0 | Ibrutinib impurity 6;1,3-bis((3R)-3-(4-amino-3-(4-phenoxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)propan-1-one | C47H46N12O3 |
| 1991986-30-1 | 2-(((4-Methylphenyl)sulfonyl)amino)-N-(4-phenyl-2-thiazolyl)-4-(trifluoromethyl)benzamide | C24H18F3N3O3S2 |
| 1997361-85-9 | Semaglutide Acetate;acetic acid;18-(((1S)-4-(2-(2-(2-(2-(2-(2-(((5S)-5-(((2S)-2-(((2S)-2-(((2S)-5-amino-2-((2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S,3R)-2-(((2S)-2-(((2S,3R)-2-((2-(((2S)-2-((2-(((2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl)amino)-2-methylpropanoyl)amino)-4-carboxybutanoyl)amino)acetyl)amino)-3-hydroxybutanoyl)amino)-3-phenylpropanoyl)amino)-3-hydroxybutanoyl)amino)-3-hydroxypropanoyl)amino)-3-carboxypropanoyl)amino)-3-methylbutanoyl)amino)-3-hydroxypropanoyl)amino)-3-hydroxypropanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-4-methylpentanoyl)amino)-4-carboxybutanoyl)amino)acetyl)amino)-5-oxopentanoyl)amino)propanoyl)amino)propanoyl)amino)-6-(((2S)-1-(((2S)-1-(((2S,3S)-1-(((2S)-1-(((2S)-1-(((2S)-1-(((2S)-1-(((2S)-5-carbamimidamido-1-((2-(((2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-4-carboxy-1-oxobutan-2-yl)amino)-6-oxohexyl)amino)-2-oxoethoxy)ethoxy)ethylamino)-2-oxoethoxy)ethoxy)ethylamino)-1-carboxy-4-oxobutyl)amino)-18-oxooctadecanoic acid | C189H295N45O61 |
| 2002381-31-7 | 6,7-Dimethoxy-N-(2-methyl-4-phenoxyphenyl)-4-quinazolinamine hydrochloride (1:1) | C23H21N3O3.HCl |
| 2004659-83-8 | Sorafenib Related Compound 11;N-methyl-4-(4-(2-(methylcarbamoyl)pyridin-4-yl)oxyanilino)pyridine-2-carboxamide | C20H19N5O3 |
| 2004659-84-9 | Sorafenib EP Impurity B;4-(4-(Formylamino)phenoxy)-N-methyl-2-pyridinecarboxamide | C14H13N3O3 |
| 2007924-97-0 | Methyl (3R,5S)-rel-5-(trifluoromethyl)piperidine-3-carboxylate HCl | C8H13ClF3NO2 |
| 2009020-38-4 | (2'-(amino-κN)(1,1'-biphenyl)-2-yl-κC)(bis(1,1-dimethylethyl)(3-methoxy-6-methyl-2',4',6'-tris(1-methylethyl)(1,1'-biphenyl)-2-yl)phosphine-κP)(methanesulfonato-κO)-Palladium;RockPhos Pd G3 | C44H62NO4PPdS |
| 2009273-71-4 | 6'-Amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-(3,3'-bipyridine)-6-carboxamide | C20H20N4O2 |
| 2012607-27-9 | N-(1,1-Dimethylethyl)-1-(1-(5-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)-2-pyridinyl)-4-piperidinyl)-1H-imidazole-5-carboxamide;WNK 463 | C21H24F3N7O2 |
| 2023006-41-7 | t-Butyl (4S)-4-(methoxymethyl)-2,2-dioxo-oxathiazolidine-3-carboxylate | C9H17NO6S |
| 2023788-19-2 | Tirzepatide;LY 3298176; LY3298176; 20-((4-(2-(2-(2-(2-(2-(2-((5-((5-amino-2-(2-((2-((6-amino-2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-((2-amino-3-(4-hydroxyphenyl)propanoyl)amino)-2-methylpropanoyl)amino)-4-carboxybutanoyl)amino)acetyl)amino)-3-hydroxybutanoyl)amino)-3-phenylpropanoyl)amino)-3-hydroxybutanoyl)amino)-3-hydroxypropanoyl)amino)-3-carboxypropanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-3-hydroxypropanoyl)amino)-3-methylpentanoyl)amino)-2-methylpropanoyl)amino)-4-methylpentanoyl)amino)-3-carboxypropanoyl)amino)hexanoyl)amino)-3-methylpentanoyl)amino)propanoylamino)-5-oxopentanoyl)amino)-6-((1-((1-((1-((5-amino-1-((1-((1-((1-((1-((2-((2-(2-((1-((1-((2-((1-(2-(2-(2-((1-amino-3-hydroxy-1-oxopropan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)pyrrolidine-1-carbonyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-2-oxoethyl)amino)-3-hydroxy-1-oxopropan-2-yl)amino)-3-hydroxy-1-oxopropan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-oxoethyl)amino)-2-oxoethyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-1,5-dioxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)amino)-6-oxohexyl)amino)-2-oxoethoxy)ethoxy)ethylamino)-2-oxoethoxy)ethoxy)ethylamino)-1-carboxy-4-oxobutyl)amino)-20-oxoicosanoic acid | C225H348N48O68 |
| 2029049-79-2 | N-(3-oxo-3-(((1R)-1,2,3,4-tetrahydro-1-naphthalenyl)amino)propyl)-4-(trifluoromethoxy)-benzamide | C21H21F3N2O3 |
| 2029205-64-7 | 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo(3,4-c)pyridine-3-carboxamide | C24H22ClN5O3 |
| 2030182-41-1 | 3-(3-Chloro-4-methoxyphenyl)-1,1-bis((2H3)methyl)urea | C10H7D6ClN2O2 |
| 2030242-21-6 | Enzalutamide Impurity 7;Enzalutamide metabolite M7;4-(3-(3-fluoro-4-(methylcarbamoyl)phenyl)-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl)-2-(trifluoromethyl)benzamide | C21H18F4N4O3S |